Results 41 to 50 of about 674,512 (170)
PARP inhibitors in prostate cancer: time to narrow patient selection? [PDF]
Mark C. Markowski +1 more
openalex +1 more source
Introduction: Prostate biopsy results form the mainstay of patient care. However, there is often significant discordance between the biopsied histology and the ‘true’ histology shown on a radical prostatectomy (RP).
Peter Stapleton +3 more
doaj +1 more source
Background We performed a prospective phase II study to compare acute toxicity among five different hypofractionated schedules using proton therapy. This study was an exploratory analysis to investigate the secondary end-point of biochemical failure-free
Boram Ha +13 more
doaj +1 more source
MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells [PDF]
Robert S. Bayne +9 more
openalex +1 more source
Evaluation of Treatment Patterns and Costs in Patients with Prostate Cancer and Bone Metastases [PDF]
Lonnie Wen +2 more
openalex +1 more source
Black men suffer disproportionately from prostate cancer (PCa) compared to men of other races and ethnicities. Comparing the molecular landscape of PCa among Black and White patients has the potential to identify targets for development of new precision ...
Muthana Al Abo +23 more
doaj +1 more source
Predisposing factors underlying familial aggregation of non-syndromic gliomas are still to be uncovered. Whole-exome sequencing was performed in four Finnish families with brain tumors to identify rare predisposing variants. A total of 417 detected exome
Riikka Nurminen +16 more
doaj +1 more source
Metallic prostate stapling (e.g., UroLift) is a minimally invasive treatment option for men with bladder outlet obstruction from benign prostatic hyperplasia (BPH).
Jianliang Liu +2 more
doaj +1 more source
Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
Introduction. To assess the performance of five previously described clinicopathological definitions of low-risk prostate cancer (PC). Materials and Methods. Men who underwent radical prostatectomy (RP) for clinical stage ≤T2, PSA
Pim J. van Leeuwen +9 more
doaj +1 more source

